Cite
HARVARD Citation
Iking-Konert, C. et al. (2011). Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria. Annals of the rheumatic diseases. 70 (11), pp. 1986-1990. [Online].